Delayed-onset heparin-induced thrombocytopenia and thrombosis.
about
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patientsHeparin induced thrombocytopenia: diagnosis and management updateHeparin-induced thrombocytopenia: an updateIdiosyncratic adverse drug reactions: current conceptsHITlights: a career perspective on heparin-induced thrombocytopeniaA systematic evaluation of laboratory testing for drug-induced immune thrombocytopeniaVenous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplastyAcute coronary syndromes: diagnosis and management, part IProthrombotic States that Predispose to Stroke.The pathophysiology of immune-mediated heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathogenesis and management.Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.Laboratory diagnosis of heparin-induced thrombocytopenia in Asian Indians as investigated with functional and immunologic methods.Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass.Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.Coronary artery stent thrombosis associated with heparin-induced thrombocytopenia: case report and review of the literature.Heparin-induced thrombocytopenia--a potential iatrogenic complication for patients with cardiac and vascular disease.Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After ThrombocEtiology of thrombocytopenia in all patients treated with heparin products.Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin.Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin?Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.Delayed-onset heparin-induced thrombocytopenia and thrombosis after intraoperative heparin anticoagulation-four case reports.New concepts in heparin-induced thrombocytopenia: diagnosis and management.Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence.Heparin-induced thrombocytopenia and recent advances in its therapy.Heparin-induced thrombocytopenia in myeloproliferative disorders: a rare or under-diagnosed complication?Higher optical density of an antigen assay predicts thrombosis in patients with heparin-induced thrombocytopenia.Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushesThrombocytopenia associated with antithrombotic therapy in patients with cardiovascular diseases: diagnosis and treatment.Current concepts review: heparin-induced thrombocytopenia.Review: recent advances in argatroban-warfarin transition in patients with heparin-induced thrombocytopenia.Pathobiology of secondary immune thrombocytopenia.False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus.
P2860
Q24200589-F9006746-DBAD-491D-BA76-49BB42271313Q24647207-FABD9B09-E01A-4111-B466-CD27AE00FA29Q24815767-E2440729-3A19-4F26-9237-F3D518407FDBQ26824391-D295E12D-65C3-4B71-8271-2AE8DE993D0DQ26828351-F1B36276-2779-42A8-A16C-2E85218CE7D9Q27686838-A25B5D21-AB31-49BA-BCFE-0529DDB5574DQ28194729-C4F182C6-B0EF-4335-99AD-47387FE90E91Q30490718-63023816-8BCE-432E-B328-405627276FE9Q33344461-8A1B3EFD-17A1-4ADD-87DE-82C451690359Q33346146-D9BE6549-B718-42A4-B67E-7CD12A2EB656Q33348049-5DC8DAF8-C87D-4536-A196-83126510E042Q33358346-9982BCF4-3FDE-48FF-9781-4B3C82DB429AQ33359675-0918E53B-6CD5-4834-BCE4-5B6DAD762C8EQ33363740-5F763D72-345C-4411-8D7A-222FA207C2FEQ33364046-910A83B6-9A6F-4BC7-B0FB-2954CE1BF874Q33366197-E89F8419-565A-4974-8F99-D392740B4377Q33366273-601D33C8-74F6-402B-83A0-008CCA47EF05Q33366916-988C1881-1105-45AF-B867-1596149A9102Q33367107-563DC2D5-B80F-4DBC-A3F3-D6DC145A2AC2Q33368347-60660A50-44A5-47AE-897B-234FDC1566A1Q33368721-57DF383F-2F2D-4F99-87EB-DCFF1D44958EQ33369316-530FD57A-712C-49D5-833E-5F4E5EE7DA2CQ33370185-782B4511-0273-4EA4-BEF2-FDC4BAA27558Q33370257-52CE256A-4BC4-4E05-AA0A-500E9EA01540Q33371593-B6A3CEFD-6684-4562-AB1A-868A2B1297CEQ33372179-CEA0961F-3D9D-47D3-9E34-DA7B114633BBQ33374174-442E509C-36C6-4FD6-89A3-B064996BC0DCQ33375570-8A84A4DA-5DB8-4705-B287-8F855BE0B4FFQ33376872-E37E8CA1-7393-407A-94BC-36CA682F8825Q33377436-E2147033-6C26-4792-9AF2-358912ACE5D9Q33378189-EB09ECD0-6D39-495E-A916-A44C0E4AE2B0Q33378353-840FC744-8E79-43EC-8473-FC28A839F827Q33379665-E8CAE7EF-0BA4-4645-AA2A-A05987ED12FBQ33381223-0F67F599-7536-4EF0-A417-6C814ACF3201Q33381352-0035CFD2-83E5-4EA8-891E-8CF0F3FB1F66Q33381366-55485886-B5FD-4BD9-90EE-C9A33CF3CDDFQ33382108-19C5685E-3648-4DC9-BAE9-755FB8411C10Q33382275-AE5BF1E7-D9EC-47DE-A4FB-D8575D31E2DBQ33383468-66454393-2C18-481C-A964-3C539CA1C84CQ33383739-6FD40173-8B92-4BCC-A838-B6D453F6AEF7
P2860
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@ast
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@en
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@nl
type
label
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@ast
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@en
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@nl
prefLabel
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@ast
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@en
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@nl
P1476
Delayed-onset heparin-induced thrombocytopenia and thrombosis.
@en
P2093
P304
P356
10.7326/0003-4819-135-7-200110020-00009
P407
P577
2001-10-01T00:00:00Z